Gelfoam Market Size, Share, Growth, And Industry Analysis, By Type (Sponge and Powder) By Application (Minimally Invasive Surgery, General Surgery, and Others), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

GELFOAM MARKET OVERVIEW

The global Gelfoam Market was valued is expected to rise to USD 1.073 billion in 2025, eventually reaching USD 1.709 billion by 2034, expanding at a CAGR of 5.91% from 2025 to 2034.

The United States Gelfoam market size is projected at USD 0.334 billion in 2025, the Europe Gelfoam market size is projected at USD 0.313 billion in 2025, and the China Gelfoam market size is projected at USD 0.288 billion in 2025.

Gelfoam is a medical device that aids in the speedy clotting of blood. It is an off-white, nonelastic product prepared from gelatin. Gelfoam also has the added properties of being water-insoluble and porous. Gelfoam doesn’t alter the internal working of the body in relation to blood clotting. It rather works more on the physical, external aspect of blood clotting. Gelfoam should be used in small quantities, for it to get completely absorbed when applied on bleeding surfaces. It also shows little tissue reaction when used in small amounts. Apart from the quantity of gelfoam used, the absorption process is also dependent on the site where it is used and the degree of saturation of the blood.

When gelfoam is used in soft tissues, it is generally absorbed in approximately four to six weeks, with no major scar tissue. When used in bleeding nasal or reproductive areas, gelfoam is completely absorbed in about two to five days.

KEY FINDINGS

COVID-19 IMPACT

Halt of Operations to Impede Growth

The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic has disrupted all areas of business and production. The lockdowns which were imposed halted production activities of gelfoam. The major manufacturers and users of gelfoam, North America and Europe, suffered enormously due to COVID-19, whether in terms of the number of people infected or the regression of the economy. The supply chain was completely disrupted and exports and imports were harder to manage. This led to a reduced usage of gelfoam in other parts of the world as well. People started receiving only the essential treatments and postponed the others. This was because of the poor financial position of people during the pandemic. Many people lost their employment, a lot of businesses failed and families lost their breadwinners. So, any expensive treatments were put on the backburner during the pandemic. So, the COVID-19 pandemic negatively impacted the gelfoam market growth.

LATEST TRENDS

Expanding Use of Gel-Flow Kits for Various Purposes to Support Growth

The gel-flow NT kit is a product launched by Pfizer which combines gelfoam and thrombin-JMI. This product comes in the form of a handy kit and could be very popular in the hemostatic sphere of products. This combination of gelfoam and thrombin-JMI provides the advantage of variable viscosity levels based on different needs and uses. It also delivers 5000 IU of thrombin in the final mixture. Perhaps one of the most important features of gel-flow NT kit is that it allows for complete sterilization of the preparation process. The use of gelfoam during surgical procedures has the risk of infections. But the use of gel-foam NT kit provides sterility. The gelfoam market is anticipated to grow due to these innovations in the market by different companies.

• According to clinical data published by the U.S. National Library of Medicine, over 500,000 surgical procedures annually in the U.S. alone now incorporate absorbable hemostatic agents like gelfoam, driven by reduced surgical time and recovery benefits.

• In Europe, the demand for gelatin-based surgical sponges has increased by 18% between 2021 and 2023, with innovation in combo kits like gel-flow NT leading to higher adoption across orthopedics and neurosurgery.

Request a Free sample to learn more about this report

GELFOAM MARKET SEGMENTATION

By Type

On the basis of type, the gelfoam market can be divided into sponge and powder. The sponge segment holds the majority of the gelfoam market share.

By Application

According to application, the gelfoam market can be segmented into minimally invasive surgery, general surgery, and others. General surgery dominates the gelfoam market.

DRIVING FACTORS

Aging Population to Stimulate Demand

As the healthcare facilities have been constantly improving, the average lifetime of the population is also increasing. People are living longer. But with age comes the need for a lot of medical procedures. People above the age of 65 require more soft tissue treatments and are more prone to diseases. This is where general surgery comes into play. With an increase in the population, more people need to receive treatments for their ailments. Most of the regular procedures taken by the elderly population fall under the ambit of general surgery. The number of general surgery cases is rising every year. General surgery procedures require the use of gelfoam for bleeding control and other uses. As the number of general surgery cases is increasing, it is going to boost the demand for gelfoam.

Growing Use of Gelfoam in Dentistry to Boost Demand

Gelfoam is used by dentists in the oral health sector. While gelfoam is extensively used during general surgery, it is also an aid in the process of oral surgery. Gelfoam is used in oral surgery for two important reasons. One is the traditional use of blood clotting, other is to fill in the dead space in the mouth. In the cases of oral surgery, gelfoam does not need to be mixed with thrombin to achieve results. This helps is reducing costs. Since it has absorbing properties, it is a great advantage in oral surgeries. There are also fewer cases of complications after the operation and the need for prolonged treatments is reduced. Gelfoam is a huge aid in dentistry and as people start visiting dentists more, it can be a significant addition to the gelfoam market.

• As per WHO projections, the global population aged 65+ is expected to surpass 1.5 billion by 2050, significantly increasing surgical needs where gelfoam is routinely used for blood clotting and tissue support.

• In the U.S., general surgical procedures rose by 11% from 2019 to 2023, and gelfoam was utilized in nearly 70% of soft-tissue and general surgery cases, indicating its essential role in modern operating rooms.

RESTRAINING FACTORS

Dangerous Effects of Gelfoam to Challenge Growth

While gelfoam is commonly used in surgical procedures, it also comes with factors that need to be meticulously checked and maintained to prevent damage. Gelfoam should never be used in case of infections or contaminations. If infections occur in areas where gelfoam has already been used, another surgery might be required to treat the same. In many procedures, gelfoam should be removed as soon as hemostasis is achieved, otherwise there are possibilities of swelling and nerve damage. As the use of gelfoam can produce some harmful effects, it can only be used in small amounts.

• Gelfoam should not be used in the presence of active infections; clinical guidelines report a 7–10% post-operative complication rate in procedures where gelfoam was used in contaminated fields.

• According to surgical safety advisories, improper or excessive use of gelfoam in confined spaces has resulted in neurological complications in 4–6% of spine surgery cases, underscoring usage limitations.

• Request a Free sample to learn more about this report

•  

GELFOAM MARKET REGIONAL INSIGHTS

North America is the largest consumer of gelfoam with a substantial market share. The North American region is one of the most medically-developed regions of the world. With world-class healthcare facilities and infrastructure, the medical equipment gelfoam is the most used here. People from all over the world travel to the North American region for medical reasons and availing of its medical facilities. Sizable procedures like general surgery are also extremely common here. That is the reason why North America is the largest consumer of gelfoam.

Europe follows North America to take second place in terms of consumption of gelfoam., with a market share of about 31%. Europe also boasts of having a well-developed healthcare infrastructure. Many countries in Europe also provide the facility of free healthcare and medical procedures or charge a very affordable fee. This is one of the reasons why Europe’s healthcare is reputed worldwide. Europe also sees a lot of medical tourists. So, Europe holds a significant portion of the gelfoam market size.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Johnson & Johnson (U.S.): The company’s SURGIFOAM® product line is used in more than 75 countries, and accounts for an estimated 40 million surgical applications annually.

• Gelita Medical (Germany): Offers hemostats derived from pharmaceutical-grade gelatin with a production capacity exceeding 100 million sponges per year, primarily targeting dental and veterinary sectors.

List of Top Gelfoam Companies

• Johnson and Johnson (U.S.)
• Gelita (Germany)
• Pfizer (U.S.)
• Baxter (U.S.)
• Ferrosan Medical Devices (Denmark)
• B Braun (Germany)
• Equimedical (Netherlands)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.